










Title of Document: ASSESSING HEARING LOSS DUE TO 
OTOTOXIC DRUGS IN THE ZEBRA FINCH 
  
 Kristina Michelle DeAngelo, Master of Science, 
2008 
  




Aminoglycosides such as kanamycin and amikacin are ototoxic drugs that cause hair 
cell damage/loss that leads to hearing loss in humans and animals.  Previous studies 
show both hearing loss and recovery following administration in birds.  I assessed the 
effects of aminoglycoside treatment in the budgerigar, canary, and zebra finch using 
auditory brainstem response (ABR).  The purpose of this study was to determine 
whether the ABR can accurately measure hearing loss following treatment, and to 
compare the effect of two aminoglycosides on zebra finch hearing sensitivity. After 
treatment, budgerigar and canary ABR audiograms were similar to those found 
through behavioral methods confirming the ABR as an efficient tool to measure 
hearing loss and recovery.  Interestingly, zebra finches did not show the expected 
hearing loss but instead showed small threshold shifts across all frequencies.  Overall, 
the zebra finch appears to be far less susceptible to aminoglycoside induced hearing 
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In humans and mammals noise overexposure and/or ototoxic drugs, such as 
aminoglycosides, cause permanent hair cell damage/loss and lead to hearing loss 
(Husmann et al., 1998).  Birds are one of few species to show recovery of hearing 
after noise overexposure and/or ototoxic treatment.  Studies show hair cell 
regeneration and subsequent recovery of hearing sensitivity, to near normal levels, 
begin to occur in all tested avian species as early as several days after aminoglycoside 
treatment (Husmann et al., 1998; Cotanche, 1999; Wooley et al., 2001; Dooling et al., 
2006; Dooling et al., in prep). 
The auditory brainstem response (ABR) technique has been used to assess 
hearing sensitivity in various avian species including budgerigars (Melopsittacus 
undulatus) (Brittan-Powell et al., 2002), Bengalese finches (Lonchura striata 
domestica) (Wooley and Rubel, 2002), eastern screech owls (Megascops asio) 
(Brittan-Powell et al., 2005), and zebra finches (Taeniopygia guttata) (Amin et al., 
2007; Noirot et al., 2006).  In Bengalese finches, Woolley et al. (2001) assessed 
changes in hearing sensitivity due to ototoxic drug exposure using the ABR.   
The current study focuses on the zebra finch.  Zebra finches are small birds 
that learn their song from a male tutor within the first few weeks of life, and then sing 
the same song throughout adulthood (Catchpole and Slater, 1995; Lombardino and 
Nottebohm, 2000).  Because these birds, along with other songbirds and parrots, learn 
through auditory feedback, they serve as good models of vocal development and 




The purpose of this thesis was two-fold.  The first objective was to confirm 
that the ABR serves as a good measure of hearing sensitivity after aminoglycoside 
treatment in the budgerigar and canary by comparing results to previous behavioral 
data in the two species.  The second objective was to compare the effect of two 
aminoglycoside treatments on hearing sensitivity in the zebra finch. 
First, hearing sensitivity after aminoglycoside treatment was measured in the 
budgerigar and canary using the ABR technique.  Subjects were administered a ten-
day cycle of kanamycin (KM), and hearing sensitivity was measured at set time 
periods.  After KM, ABR audiograms showed loss of sensitivity, but thresholds were 
higher than those found in the two species through behavioral methods.  The general 
shift in sensitivity due to hair cell loss was similar despite method (behavior vs. 
ABR).  Thus, the ABR was confirmed as an efficient tool to measure aminoglycoside 
induced hearing loss and subsequent recovery in the budgerigar and canary. 
Next, hearing sensitivity after KM treatment was examined in the zebra finch.  
Due to the extreme toxic effects of the antibiotic, subjects were administered a 
slightly decreased dosage of the ten-day treatment. ABR audiograms did not display 
parallel results to those found in the budgerigar and canary.  Instead of the anticipated 
high frequency loss, the zebra finch showed a very small loss in hearing sensitivity 
across all frequencies tested.  Histological studies showed little to no change in the 
basilar papilla. 
To assure that the modified dosage did not cause these unusual results, two 




audiograms were the same in budgerigars despite the difference in dose, thus both 
dosages are sufficient enough to cause hearing damage. 
Finally, the effects of another aminoglycoside, amikacin, were examined in 
the zebra finch.  Here, again, subjects were administered a ten-day dosage of the 
antibiotic.  ABR audiograms displayed no change in hearing sensitivity at any of the 
time periods.  Histological studies revealed little to no hair cell damage or loss in the 
basilar papilla.  Overall, the zebra finch appears to be less susceptible to 
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Introduction 
Aminoglycosides are antibiotics that cause profound toxic and functional 
effects in the kidneys as well as significant cochlear hair cell damage in humans, 
which manifests itself as impaired hearing in the high frequency range (Gulick et al., 
1989; see review in Humes, 1999).  In the United States alone, an estimated 4 million 
courses of ototoxic antibiotics, such as aminoglycosides, are distributed to patients 
each year (see review in Fischnel-Ghodsian, 1999).  These antibiotics are typically 
prescribed for a duration of ten days (Cotanche, 1999), and are used around the world 
to treat such illnesses as tuberculosis, bronchitis and otitis media (see review in 
Fischnel-Ghodsian, 1999).  Of those humans treated with aminoglycosides, 
approximately 2-5% develop clinically significant, permanent hearing loss (see 
review in Fischnel-Ghodsian, 1999). 
Aminoglycoside induced hearing loss also occurs in many avian species such 
as the budgerigar, canary, Bengalese finch, and broiler chicken (Cotanche, 1999; 
Dooling et al., 1997; Dooling et al., 2006; Husmann et al., 1998; Woolley et al., 
2001).  In birds, the associated hearing loss is due to profound hair cell damage 
marked by hair cell loss and misorientation, primarily with hair cells in the basal end 
of the basilar papilla where high frequency sounds are encoded (Cotanche, 1999; 
Dooling et al., 2006; Dooling et al., in press; Husmann et al., 1998; Woolley et al., 
2001).  In the occasional instance of extended hearing loss (dependent upon time 
and/or dose), damage then travels through the mid-range frequencies and moves 
toward the apical end where low frequency sounds are encoded (Woolley et al., 2001; 




An important difference between birds and mammals is that avian species 
have the ability to recover hearing sensitivity through the regeneration of lost or 
damaged inner ear hair cells.  For all birds tested to date, hair cell regeneration and 
hearing recovery, back to near normal threshold levels, begins in the basilar papilla as 
early as several days after aminoglycoside treatment (e.g. Cotanche, 1999; Dooling et 
al., 1997, Dooling et al., 2006; Dooling et al., in press; Husmann et al., 1998; 
Woolley et al., 2001).  The end results are regenerated hair cells that are similar in 
appearance to normal, mature hair cells, but can be recognized by the misorientation 
of stereocilia bundles (Dooling et al., 1997; Dooling et al., 2006; Dooling et al., in 
press; Woolley et al., 2001). 
Behavioral, physiological, and histological studies have successfully 
demonstrated and measured this high frequency hearing loss, followed by hair cell 
recovery and function of hearing in a variety of avian species (e.g. Dooling et al., 
2006; Dooling et al., in press; Woolley et al., 2001; Woolley and Rubel, 2002).  Two 
such studied aminoglycosides that are known to produce this predominately cochlear 
damage with subsequent recovery are kanamycin (KM) and amikacin (reviewed in 
Fischnel-Ghodsian, 1999).  The two drugs are very similar in function, yet amikacin 
has far less toxic effects on the kidneys than kanamycin. 
There are three studies examining the effects of aminoglycoside treatment in 
budgerigars and canaries (Dooling et al., 1997; Dooling et al., 2006; Dooling et al., in 
press).  These studies use behaviorally trained birds to measure high frequency 
hearing loss, followed by regeneration of hair cells and recovery of hearing 




is presented and refrain from pecking the LED when the tone is absent; the 
presentation intensity level varies for each tone to establish the lowest intensity at 
which the bird can hear or the absolute threshold (Dooling et al., 1997; Dooling et al., 
2006; Dooling et al., in press). 
Dooling et al. (1997) examined auditory perception and vocalizations before, 
during, and after hair cell loss and recovery due to aminoglycoside treatment.  
Budgerigars were administered eight 200 mg/kg/day kanamycin injections. After six 
days of injections, the basal end of the basilar papilla was nearly devoid of all hair 
cells.  Six days later (4 days post completion of injections) regenerating hair cells 
were found in the previously barren basal end of the basilar papilla.  Regeneration 
and recovery of hair cells continued.  Hair cell numbers were almost normal levels 
four weeks after km injections, and eight weeks later were within normal limits.  
Hearing sensitivity and vocalizations were both impaired with lost or damaged hair 
cells, but perceptual behaviors returned at a rate concurrent with hair cell regeneration 
(approximately 8 weeks after treatment), while vocal behaviors returned over a much 
shorter period of time (10-15 days after the completion of treatment). 
A similar study (Dooling et al., (2006)) administered 8 days of kanamycin 
injections (Day 1: 100 mg/kg, Day 2-8: 200 mg/kg) to budgies and examined absolute 
hearing thresholds, auditory discrimination, and perception and recognition of 
complex vocalizations.  Behavioral tests assessing hearing thresholds directly 
following KM treatment primarily showed a high frequency hearing loss with damage 
extending to all frequencies tested.  By 20 weeks post injections, hearing thresholds 




for high frequencies).  Tasks examining intensity and frequency difference limens 
showed that discriminations were relatively unaffected by exposure to the ototoxic 
drug.  Call recognition tasks ascertained that after KM administration, previously 
familiar calls were no longer familiar to the birds, and remained so even three months 
later.  Overall, this study established that while hearing sensitivity recovers to near 
normal levels, perception of vocalizations changes after hair cell loss and recovery. 
Dooling et al. (In press) used behavioral methods to compare the effects of 
kanamycin on Belgian Waterslager (BW) and Non-Belgian Waterslager (non-BW) 
canaries (Serinus canaria).  Kanamycin injections were administered over a period of 
ten days (Day 1: 100 mg/kg, Day 2-10: 200 mg/kg), and hearing sensitivity was 
assessed before, during, and after KM treatment.  Results showed that while the two 
strains of canary both displayed high frequency hearing loss followed by recovery of 
thresholds, BW canaries were less sensitive to KM treatment than non-BW canaries.  
Most significantly, BW canaries have better hearing at high frequencies after KM 
treatment than they showed before KM injections. 
Woolley et al. (2001) used the ABR technique and histological methods to 
assess hearing sensitivity after aminoglycoside treatment in Bengalese finches.  Using 
alternating doses of 150mg/kg and 300mg/kg of amikacin for a period of seven days, 
they found profound hair cell destruction followed by hair cell regeneration and 
recovery of auditory sensitivity.  One day after the completion of aminoglycoside 
treatment, no hair cells were present in the basal end of the basilar papilla.  One week 
after aminoglycoside treatment showed larger areas of missing hair cells and the 




recovery peaked at four weeks post treatment, and full hair cell regeneration was 
complete by eight weeks post amikacin treatment. 
All avian species tested to date show hearing loss followed by recovery after 
exposure to ototoxic drugs, but no work has yet been done on zebra finches (see 
Table 1).  Zebra finches are small, Australian songbirds, that along with other 
songbirds and parrots are used to study vocal development and learning in humans.  
Like humans, these birds are constrained by a critical period for vocal learning and 
use auditory feedback to both learn and maintain vocalizations (Catchpole and Slater, 
1995).  
Zebra finches are a sexually dimorphic species in which males sing and 
females do not.  Male zebra finches learn their songs within the first few weeks of life 
by imitating the songs of conspecific male tutors (Catchpole and Slater, 1995; Hough 
II and Volman, 2002; Kroodsma and Miller, 1996) and continue to produce the same 
vocalizations throughout adulthood (Lombardino and Nottebohm, 2000).  Zebra 
finches are currently considered the best model system for studying vocal 
development and learning in humans.  Because zebra finches, like all other avian 
species tested to date, also possess mechanisms of hair cell regeneration, they, unlike 
humans, are able to experience a temporary period of hearing impairment.  For this 
reason, it is interesting to study the effects of aminoglycoside treatment on zebra 
finches so that in the future researchers can investigate the implications of temporary 






SPECIES AMINOGLYCOSIDE METHOD RESULT REFERENCE
Canary Kanamycin Behavioral and Histology 
High frequency 
hearing loss 
concurrent with hair 
cell damage after 
KM injections; 
regeneration of hair 
cells and recovery of 
hearing sensitivity 
followed. 
Dooling et al., in 
press 
 
Budgerigar Kanamycin Behavioral and Histology 
Initial loss of hair 
cells and auditory 
sensitivity; hearing 
sensitivity recovers 
to near normal 
levels, perception of 
vocalizations 
changes after hair 
cell loss and 
recovery. 
Dooling et al., 
2006 
 
Budgerigar Kanamycin Behavioral and Histology 
Initial loss of hearing 
and vocal production 
abilities. Perceptual 
behaviors returned at 
a rate concurrent 
with hair cell 
regeneration; vocal 
behaviors returned 
much faster.   








hearing loss followed 
by hair cell 
regeneration and 
recovery of hearing 
sensitivity which 
peaked at 4 weeks 
post treatment. 




Table 1: A brief summary of 4 studies that have successfully demonstrated and measured 






In the following experiments, I assessed aminoglycoside induced hearing loss 
and recovery in budgerigars, canaries, and zebra finches using the ABR technique.  
The purpose of the first experiment was to confirm the ABR as an efficient tool to 
measure aminoglycoside induced hearing loss and subsequent recovery in the 
budgerigar and canary.  The Experiment 2 & 3 examined the effects of 
aminoglycosides on zebra finch hearing sensitivity.  Subjects were divided into two 
groups: one group received a ten day treatment of KM, the other received a ten day 
treatment of amikacin.  Changes in hearing sensitivity and anatomy from the two 
groups were compared.  The purpose of these experiments was to determine if these 
two aminoglycosides have similar effects on hearing in zebra finches and to compare 
hearing loss in zebra finches to published data on other avian species (such as the 




Hearing sensitivity was assessed using the ABR at various times throughout 
the study.  These were 1) prior to the administration of the aminoglycoside (predata), 
2) after 6 days of aminoglycoside treatment (day 6), 3) three days after the 
completion of the injections (day 14), and 4) subsequently at weekly intervals 
following the administration of the full cycle of the aminoglycoside for a period of 
approximately two months. 
It is important to note that data were not collected for all birds at each of the 




birds died prior to completion of the study.  As such, the number of subjects assessed 




Prior to all ABR recordings, subjects were anesthetized with an intramuscular 
injection of ketamine (25-50mg/kg) and diazepam (2mg/kg).  Typically, this dosage 
is effective enough for the bird to remain sedated for approximately a period of one 
hour (Brittan-Powell et al., 2002).  
If the standard dosage of anesthesia was not adequate, a second (half of the 
original) dosage of ketamine was administered.  If the subject was still resistant, a 
third and final injection of one half of the original ketamine dosage was again 
injected.  In the rare instance that after the third injection the bird was still not 
anesthetized, the experiment was terminated and the bird was then placed into a 
therapy unit to fully recover. 
Ketamine, like other anesthetics, may cause a multitude of side effects.  
Interestingly, zebra finches displayed extremely high hearing thresholds for 
approximately one hour beginning immediately after the injection, then with time, 
thresholds slowly lowered to normal.  Additionally, in all three species, several birds 
experienced a severe allergic reaction and died immediately after the injection (per 







Once anesthetized, each bird was securely wrapped in a small cloth to 
maintain warmth and hinder any movement.  Electrodes were placed subcutaneously 
under the skin at the vertex (active), behind the ipsilateral canal opening (reference), 




Figure 1: A sedated canary wrapped in a cloth with electrodes inserted.  Electrodes 
are placed subcutaneously under the skin at the vertex (active), behind the ipsilateral 









The stimulus presentation, ABR acquisition, equipment control, and data 
management were coordinated using a Tucker-Davis Technologies System 3 modular 
rack-mount system controlled by a F15 Gigabit interface module cable-linked 2.66-
GHz Pentium4 PC containing a TDT P15 Gigabit interface PCI card and running 
TDT SIGGEN and BIOSIG software.  
Sound stimuli in the form of tone burst trains were delivered using a JBL 
speaker model 2105H (James B Lansing Sounds Inc.) placed 30 cm from the bird’s 
right ear.  Individual tone bursts were 5 ms in duration with a 1 ms rise/fall and were 
presented at .5, 1, 1.5, 2, 2.86, 4, 5.7, and 8 kHz.  Rectangular–pulse broadband clicks 
were 0.1 ms in duration with a 25 ms inter-stimulus interval.  Each stimulus train 
consisted of nine single clicks or frequency tone bursts (a total of 230 ms in duration) 
that increased in intensity in either 5 or 10 dB steps, were presented at a rate of 4/s 
and acquired at 25 kHz (Brittan-Powell et al., 2002; Brittan-Powell et al., 2005). 
Each ABR waveform represented the average of 300 alternating stimulus 
presentations replicated at each intensity level.  During acquisition they were notch 
filtered at 60 Hz.  After stimulus collection, each signal was filtered below 30 Hz and 
above 3000 Hz using the BIOSIG program. 
 
Calibration 
Sound stimuli were calibrated using a Larson Davis System 824 sound level 
meter.  A ½” microphone connected to the sound level meter was placed 30 cm from 




millisecond tone bursts were played and the sound pressure level (Fast weighting dB 
A Scale), as displayed on the sound level meter, was recorded. 
 
Analysis 
ABR threshold was defined two ways.  First, threshold was estimated through 
the visual detection method and defined as 2.5 dB below the lowest intensity at which 
a response could be visually identified (e.g., Brittan-Powell et al., 2002; Brittan-
Powell et al., 2004; Brittan-Powell et al., 2005).  Thresholds were determined as the 
arithmetic mean of 1) the lowest intensity level at which a response was detected and 
2) the following intensity level in which no response was detected.  Intensity levels 
decreased at a rate of 5 dB, therefore the average of two intensity levels resulted in a 
threshold that was estimated to be 2.5 dB below the lowest intensity detected. 
The second estimate was based on the amplitude-intensity function for peak 
amplitude of wave 1 to the baseline.  The distance from the base to the peak of wave 
1 was measured and each data point was plotted.  A regression analysis was 
performed and the line of best fit estimated the threshold. 
To assure accuracy, thresholds were replicated approximately four to six times 
at each frequency tested.  Thresholds that appeared more variable were replicated 
until a more consistent estimate was achieved.   The arithmetic mean of the threshold 
estimates for each frequency tested was recorded. 
Figure 2 shows a comparison of the two methods of analysis for determining 
thresholds.  Predata ABR audiograms for the budgerigar, canary, and zebra finch 




analysis of variance (ANOVA) showed that there were no significant differences 
found among species (F[2,245]=0.931, p>.05).  More importantly, the interaction of 







































































Figure 2: ABR audiograms before aminoglycoside treatment comparing the two 
methods of analysis in the budgerigar, zebra finch and canary.  The red, closed-circle 
line displays thresholds determined by the visual detection method and the blue, 
downward-triangle line displays thresholds determined by the regression analysis 




All anatomical work was done in collaboration with Dr. Brenda Ryals at 
James Madison University.  I assisted Dr. Ryals who kindly provided the expertise 
needed to perform the histological studies.   
A total of five zebra finches (three administered KM treatment and two 
administered amikacin treatment) were used in histological studies.  Birds were 
anesthetized with an overdose of Euthosol, sacrificed by decapitation, and a direct 




PO4 buffer at pH of 7.2 was performed bilaterally.  The entire head was immersed in 
fixative and kept refrigerated overnight.  Ears were dissected out and whole mounts 
were prepared for phallodin staining and mounted on microscope slides in slow fade 
gold anti fade reagent. 
  
Experiment 1 (Kanamycin in Budgerigars and Canaries) 
Introduction 
 Behavioral studies showed a high frequency hearing loss, followed by 
regeneration of hair cells and recovery of hearing sensitivity after aminoglycoside 
treatment in both budgerigars and canaries (Dooling et al., 1997; Dooling et al., 2006; 
Dooling et al., in press).  The purpose of this study was to measure the effects of 
kanamycin in these two avian species using the ABR technique.  I hypothesized that 
ABR thresholds would show a change in hearing sensitivity that parallels those found 




Three budgerigars and one canary were used as subjects in this experiment.  
Each bird was given daily access to ample food, with the exception of the morning of 
ABR testing, and was housed in an avian vivarium at the University of Maryland, 
College Park.  The Animal Care and Use Committee at the University of Maryland, 






All birds were administered a ten-day cycle of the ototoxic drug, kanamycin 
(KM).  The daily dosages of KM were Day 1: 100 mg/kg, and Day 2-10: 200mg/kg.   
At approximately the same time every morning, each subject received an 
intramuscular injection of the antibiotic into the pectoral muscle.  Each bird’s 
chest/pectoral muscle was visually divided into four quadrants, and the daily injection 
site rotated among the divisions to help reduce bruising and scarring.  In an effort to 
help maintain the health of the subjects, because KM has such an adverse effect on 
the kidneys (Gulick et al., 1989; reviewed in Humes, 1999), each bird also received a 
second injection of (1-2cc) Lactated Ringer’s solution (Sarah Woolley, personal 
communication).  The supplementary fluids were administered through a 
subcutaneous injection inserted dorsally between the wings.   
The injection cycle occurred over a period of eleven days.  The first six 
injections were administered on days one through six, and the last four were given on 
days eight through eleven.  Subjects did not receive an injection on day seven.  
Instead, hearing sensitivity was assessed through the ABR after the sixth day of 
injections. 
 
Results and Discussion 
Hearing Sensitivity 
Figures 3A and 3B show ABR audiograms for the budgerigar and canary at 
four time periods.  Following kanamycin treatment, high frequency thresholds 




p<.01).and paralleled those found in the two species using behavioral methods 
(Dooling et al., 1997; Dooling et al., 2006; Dooling et al., in press).   
 
(A)  Budgerigar (N=3)
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(B)  Canary (N=1)
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Figure 3: ABR audiograms before KM injection (red, closed-circle line), after 6 days 
of KM injections, or day 6 (blue, downward-triangle line), 3 days post injections, or 
day 14 (green, closed-square line) and 12 days post injections, or day 23 (pink, 
closed-diamond line) for the budgerigar (a) and canary (b).  The solid black line is the 
behavioral audiogram for each species.  Arrows project estimated hearing thresholds 
at the designated frequencies.  Following six days of KM treatment, ABR audiograms 
of the budgerigar and canary hearing thresholds showed high threshold shifts similar 
to those found behaviorally due to KM administration.  At three days post the 
completion of KM treatment, budgerigar and canary threshold shifts as a function of 
frequency show substantially larger differences than those displayed after 6 days of 
injections.  By approximately 10 days post the completion of treatment, recovery of 








In both species, after six days of KM injections, ABR audiograms show 
extensive hearing loss in the high frequencies (i.e. 2.86, 4, 5.7, and 8 kHz).  This loss 
in high frequency hearing sensitivity is represented by substantial threshold shifts at 
these frequencies as evidenced for example, from a 40dB shift at 4 kHz.  The low and 
mid frequencies (i.e. .5, 1, 1.5, and 2 kHz) were relatively unaffected by the 
antibiotic.  The budgerigar showed significant changes in thresholds as a function of 
treatment (day by frequency) (F[21,54]=12.26, p<.01).  Post hoc tests showed 
significant differences in thresholds between testing day 6 and predata for the 
budgerigar (t[3]=-5.48, p<.01), but not for the canary (t[3]=-1.78, p>.05). 
After the budgerigar and canary received the full ten-day administration of the 
KM treatment, the originally restricted high frequency hearing loss expands to affect 
all frequencies tested.  Post hoc tests showed significant differences between testing 
day 14 and predata for the budgerigar (t[3]=-18.58, p<.01) and the canary (t[3]=-3.74, 
p<.01).  Though all frequencies display a loss in hearing sensitivity, the greatest 
threshold shifts remain in the high frequencies.  Threshold shifts reaching 
approximately 50 and 60 dB are recorded at select frequencies (i.e. at 4 and 2.86 kHz, 
respectively) in both budgerigars and canaries. 
Recovery of hearing sensitivity began approximately ten days after the 
completion of the KM treatment.  ABR audiograms display recovering thresholds at 
all frequencies tested for the two species (see Figures 3A and 3B).  Post hoc tests 
showed significant differences between testing day 23 and predata for the budgerigar 
(t[3]=-11.93, p<.01), but not for the canary (t[3]=-1.84, p>.05).  At day 23, thresholds 




evidence of hearing recovery.  With time, thresholds continue to slowly improve back 
to baseline levels.  These results parallel those found through behavioral methods for 
both budgerigars and canaries (Dooling et al., 2006; Dooling et al., in press). 
 
Experiment 2A (Kanamycin in Zebra Finches) 
Introduction 
The previous study showed that the ABR can be used as a valid measure of 
hearing sensitivity before, during and after aminoglycoside treatment.  The ABR 
allowed successful demonstration of a high frequency hearing loss, followed by 
regeneration of hair cells and recovery of hearing sensitivity after kanamycin 
treatment in both budgerigars and canaries.  Results from Experiment 1 mirrored 
behavioral results for the budgerigar and canary (Dooling et al., 2006; Dooling et al., 
in press).   
To our knowledge, no work has yet been done on zebra finches.  The purpose 
of this study was to measure the effect of kanamycin treatment in zebra finches using 
the auditory brainstem response and to compare the results to previous behavioral 
data in budgerigars and canaries.  I hypothesized that zebra finch ABR thresholds 
(measured before, during and after KM treatment) would show a change in hearing 










Nine zebra finches were used as subjects in this experiment.  Six zebra finches 
were used to measure hearing sensitivity before, during, and after kanamycin 
treatment.  Three zebra finches were used for histological studies.  All procedures 
were the same as above, except where noted. 
 
Kanamycin Treatment 
All birds were administered a ten-day cycle of the ototoxic drug, KM.  The 
daily dosages of KM for zebra finches were slightly lowered from the original dosage 
administered in Experiment 1.  When conducting pilot experiments, I experienced an 
extremely high mortality rate in zebra finches with the standard dosage.   Sixty 
percent (three out of five) of the subjects died as a direct result of the toxic effects of 
the antibiotic.  Necropsy reports of the birds showed severe kidney damage, and the 
cause of death for all subjects was deemed renal failure.  Therefore, the modified 
daily dosages of KM for zebra finches were: Day 1: 50mg/kg, Day 2: 100 mg/kg, Day 
3-10: 200mg/kg. 
As with Experiment 1, the injection cycle occurred over a period of eleven 
days.  The first six injections were administered on days one through six and the last 
four were given on days eight through eleven.  Subjects did not receive an injection 
on day seven.  Instead, hearing sensitivity was assessed through the ABR after the 





Results and Discussion 
Hearing Sensitivity 
Figure 4 shows an average ABR audiogram for six zebra finches at four 
different time periods.  It is important to note that due to the extreme toxicity of the 
drug, all subjects did not survive until the final assessment.  Therefore, the number of 
subjects at each measurement time period slightly varies.  ABR results display a form 











































Figure 4: ABR audiograms before KM injection (red, closed-circle line), after 6 days 
of KM injections, or day 6 (blue, downward-triangle line), 3 days post injections, or 
day 14 (green, closed-square line), and 12 days post injections, or day 23 (pink, 
closed-diamond line) for the zebra finch.  The solid black line is the behavioral 
audiogram for zebra finches.  Following six days of KM treatment, ABR audiograms 
of hearing thresholds did not show a similar pattern of high threshold shifts similar to 
those found behaviorally due to KM administration.  At three days post the 
completion of KM treatment, zebra finch threshold shifts as a function of frequency 
show only slightly increased threshold shifts as compared to those displayed after 6 
days of injections.  Approximately 12 days after the completion of treatment, 
recovery of threshold shifts is evident.   
 
 
Following 6 days of KM treatment, 4 zebra finches showed a small threshold 
shift of approximately 5 dB across all frequencies, with the greatest shifts occurring 
in the mid frequencies (i.e. 1.5, 2, 2.86, and 4 kHz).  A repeated measures ANOVA 
showed no significant difference between testing day 6 and predata across 
frequencies (F[8,24]=1.188, p>.05).  Other avian species, under the same conditions, 
show a substantial high frequency threshold shift, leaving the mid and lower 
frequencies relatively unaffected. 
Three days after the full ten-day KM course, zebra finches only show another 
slight increase of approximately 5 dB in threshold shifts across all frequencies.  This 
sums to a total shift of approximately 10 dB at all frequencies tested.  At this point 
again, the middle frequencies (1.5, 2, 2.86, and 4 kHz) appear to be most affected by 
the aminoglycoside.  A repeated measures ANOVA showed a significant difference 
between testing day 14 and predata across frequencies (F[8,40]=5.381, p<.01).  
Although results show a statistically significant difference in threshold shift between 
day 14 and predata, the zebra finch still shows only a minimal change in contrast to 




The largest species-specific differences (due to KM administration) in hearing 
threshold shifts occurs 3 days post completion of treatment.  A substantial difference 
in threshold shifts was seen at the mid to high frequencies (see Figure 5).  The most 
extensive ranges among species occur at the high frequencies.  For example, at 2.86 
kHz, the budgerigar and canary show an approximately 50 dB threshold shift whereas 
the zebra finch shift was merely 15 dB.  Six separate ANOVAs were performed to 
examine differences in threshold shifts among species by frequency – a Bonferroni 
correction was performed (p<.008).  No significant differences were found at .5 kHz 
(F[2,7]=0.281, p>.05) and 1 kHz (F[2,7]=4.328, p>.05).  A significant difference was 
found at 1.5 kHz (F[2,7]=15.449, p<.01); post hoc tests showed a significant 
difference between the budgerigar and zebra finch (t[2]=5.239, p<.008).  A 
significant difference was found at 2 kHz (F[2,7]=18.612, p<.01); post hoc tests 
showed a significant difference between the budgerigar and zebra finch (t[2]=5.785, 
p<.008).  A significant difference was found at 2.86 kHz (F[2,7]=37.886, p<.01); post 
hoc tests showed a significant difference between the budgerigar and zebra finch 
(t[2]=7.865, p<.008) and the canary and zebra finch (t[2]=5.357, p<.008).  A 
significant difference was found at 4 kHz (F[2,7]=15.998, p<.01); post hoc tests 
showed a significant difference between the budgerigar and zebra finch (t[2]=4.941, 






























Figure 5: Species-specific threshold changes at low (.5, 1 and 1.5 kHz), mid (2 and 
2.86 kHz), and high (4 kHz) frequencies following KM treatment in the zebra finch 
(black), budgerigar (light gray), and canary (dark gray). ABR thresholds were 
measured 3 days after the completion of KM treatment.  The budgerigar and canary 
experience a similar threshold shift at each of the frequencies tested.  Interestingly, 
the zebra finch shows a much smaller threshold shift at each frequency.  The most 
substantial differences in threshold shifts are exhibited at the mid and high 
frequencies. 
 
As with other avian species, recovery of hearing sensitivity in the zebra finch 
begins approximately ten days after the completion of KM treatment (see Figure 4A).  
At day 23, ABR audiograms show a 7 dB shift in thresholds back to baseline levels, 
signifying an improvement in hearing abilities.  A repeated measures ANOVA 
showed no significant difference between testing day 23 and predata across 




improvements in hearing sensitivity.  By one month, recovery of hearing sensitivity 
was near normal, but not fully achieved (see Figure 6). 
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Figure 6: Graph showing threshold shifts and recovery over time at each individual 
frequency in the KM treated zebra finch.  A substantial threshold shift is seen at day 
14, and subsequent recovery back to near normal levels begins at day 23.  Dashed 
gray lines denote injection period. 
 
Histology 
Examination of the basilar papilla of three zebra finches (0 days post KM 
course) using phallodin staining showed no hair cell loss and little to no stereocilia 
misorientation among surviving hair cells in the basal and middle regions of the 
basilar papilla (see Figure 7B).  In fact, the basilar papillae of the three zebra finches 




quite unlike the massive amount of hair cell loss and destruction that is observed in 
other avian species.  
 
 
Figure 7: (A) Basilar papilla of a normal, control zebra finch after phallodin staining. All 
hair cells are present, healthy and properly aligned. (B) Basilar papilla of a zebra finch at 
day 11 (zero days post the 10-day KM treatment course).  The circled region shows an 
area of slight stereocilia misorientation among surviving hair cells in the basal end of the 
basilar papilla.  There is very slight hair cell damage observed in the base in contrast to 
what is observed in other avian species. (C) Basilar papilla of a zebra finch at day 11 (zero 
days post the 10-day amikacin treatment course).  The circled region shows the area of 
slight hair cell loss and stereocilia misorientation among surviving hair cells in the basal 
end of the basilar papilla.  Only minimal hair cell damage is observed in the base in 








Experiment 2B (Kanamycin (at the modified ZF dosage) in Budgerigars) 
Kanamycin did not affect zebra finch hearing sensitivity the same way it did 
in budgerigars and canaries (Dooling et al., 2006; Dooling et al., in press).  Because a 
lesser kanamycin dosage was used for the zebra finch, there was question as to 
whether the aberrant results were a consequence of the modified treatment.  The 
purpose of this study was to measure the effect of the modified kanamycin treatment 
in budgerigars using the ABR, and to compare the results to ABR data in budgerigars 
receiving the original dosage.  I hypothesized that budgerigar ABR thresholds 
(measured before, during and after the modified KM treatment) would show a change 




Two budgerigars were used as subjects in this experiment.  All procedures are 
the same as above, except where noted. 
 
Kanamycin Treatment 
All birds were administered a ten-day cycle of the ototoxic drug, kanamycin 
(KM).  The daily dosages of KM for budgerigars were slightly lowered to parallel 
those given to zebra finches in Experiment 2A.  Therefore, the modified daily 





As with Experiment 1, the injection cycle occurred over a period of eleven 
days.  The first six injections were administered on days one through six and the last 
four were given on days eight through eleven.  Subjects did not receive an injection 
on day seven.  Instead, hearing sensitivity was assessed through the ABR after six 
days of injections.   
 
Results and Discussion 
Hearing Sensitivity 
The two doses of kanamycin show a similar pattern of hearing loss and 
recovery (see Figure 8).   Following the modified kanamycin treatment, high 
frequency thresholds increase and parallel those found in budgerigars in Experiment 






































Figure 8: ABR audiograms before KM injection (red, closed-circle line), after 6 days 
of KM injections, or day 6 (blue, downward-triangle line) 3 days post injections, or 
day 14 (green, closed-square line), and 12 days post injections, or day 23 (pink, 
closed-diamond line) for the budgerigar at the modified KM dose.  The solid black 
line is the behavioral audiogram for budgerigars.  Arrows project estimated hearing 
thresholds at the designated frequencies.  Following six days of KM treatment, ABR 
audiograms of the budgerigar hearing thresholds showed high threshold shifts similar 
to those found in budgerigars administered the original KM dosage.  At three days 
post the completion of KM treatment, budgerigar threshold shifts as a function of 
frequency show substantially larger differences than those displayed after 6 days of 
injections.  By approximately 10 days post the completion of treatment, recovery of 
threshold shifts is evident. 
 
 
After six days of KM injections, ABR audiograms show substantial hearing 
loss in the high frequencies (i.e. 2.86, 4, 5.7, and 8 kHz).  The low and mid 




antibiotic.  A least squares ANOVA showed a significant difference in the audiogram 
(F[31,32]=35.57, p<.01), with a significant treatment day by frequency effect 
(F[21,32]=9.65, p<.01).  A main interaction effect between day and frequency was 
present.  Post hoc tests showed significant differences between testing day 6 and 
predata for the budgerigar (t[3]=-6.95, p<.01). 
After completion of the ten-day treatment cycle, the originally restricted high 
frequency hearing loss expands to affect all frequencies tested.  Though all 
frequencies display a loss in hearing sensitivity, the greatest threshold shifts are in the 
high frequencies.  Threshold shifts reaching approximately 57 dB are recorded at 
select frequencies (i.e. at 2.86 kHz) in budgerigars.  As Figure 9 shows, at day 14, the 
threshold shifts exhibited by budgerigars receiving the modified daily dosage of KM, 
parallels the results of budgerigars administered the original dosage of KM.  Post hoc 
tests showed significant differences between testing day 14 and predata across 




























Figure 9: ABR audiograms before KM injection (red, closed-circle line), after 6 days 
of KM injections, or day 6 (blue, downward-triangle line) 3 days post injections, or 
day 14 (green, closed-square line), and 12 days post injections, or day 23 (pink, 
closed-diamond line) for the budgerigar at the modified KM dose.  The solid black 
line is the behavioral audiogram for budgerigars.  Arrows project estimated hearing 
thresholds at the designated frequencies.  Following six days of KM treatment, ABR 
audiograms of the budgerigar hearing thresholds showed high threshold shifts similar 
to those found in budgerigars administered the original KM dosage.  At three days 
post the completion of KM treatment, budgerigar threshold shifts as a function of 
frequency show substantially larger differences than those displayed after 6 days of 
injections.  By approximately 10 days post the completion of treatment, recovery of 
threshold shifts is evident. 
 
 
Recovery of hearing sensitivity begins approximately ten days after the 
completion of the KM treatment (see Figure 8).  ABR audiograms display recovering 




reach approximately 16 dB at select frequencies, showing the beginning of hearing 
sensitivity recovery.  Post hoc tests showed significant differences between testing 
day 23 and predata across frequencies for the budgerigar (t[3]=-11.64, p<.01). 
Assessment approximately ten days later, day 32, displays further recovery of 
hearing sensitivity at all frequencies.  At this time, budgerigar thresholds have 
improved on average an additional 10-15 dB from that recorded at day 23 (12 days 
post completion of administration).  With time, hearing sensitivity continues to 
recover; by day 46, approximately one month after the completion of kanamycin 
treatment, all thresholds have nearly returned to baseline.   
Recovery of hearing sensitivity was not fully achieved even by day 46.  
Instead, the budgerigar exhibited recoveries that culminated in near normal hearing 
levels.  These results paralleled those found through both ABR methods and 
behavioral methods for budgerigars (see Experiment 1; Dooling et al., 2006). 
 
Experiment 3 (Amikacin in Zebra Finches) 
Introduction 
Results evaluating the effect of kanamycin on zebra finch hearing sensitivity 
did not display a hearing loss pattern similar to those found behaviorally and 
physiologically in budgerigars and canaries (Dooling et al., 2006; Dooling et al., in 
press).  Woolley et al. (2001) studied the effects of another aminoglycoside, 
amikacin, on hearing sensitivity in Bengalese finches.  Results from the study showed 
a similar hearing loss pattern to those displayed behaviorally in budgerigars and 




treatment in zebra finches and to compare results to those found after kanamycin 
treatment in zebra finches and amikacin treatment in Bengalese finches.  I 
hypothesized that zebra finch ABR thresholds (measured before, during and after 
amikacin treatment) will show a change in hearing sensitivity that parallels those 




Five zebra finches were used as subjects in this experiment to assess hearing 
sensitivity before, during, and after amikacin treatment.  Two of the five subjects used 
to assess hearing sensitivity were additionally used for histological studies.  
Therefore, the number of subjects examined after predata and day 6 assessments 
decreased by two subjects.  Additionally, one zebra finch died before the conclusion 
of the study from an allergic reaction to the ketamine injection given as an anesthetic 
before the ABR.  All procedures were the same as above, except where noted. 
 
Amikacin Treatment 
All birds were administered a ten-day cycle of the ototoxic drug, amikacin.  
The daily doses of the antibiotic were Day 1: 50 mg/kg, Day 2: 100 mg/kg, and Days 
3-10: 200 mg/kg. This dosage was a direct comparison with KM administered to 
zebra finches in Experiment 2A, but varied from the alternating 150mg/kg and 
300mg/kg dosage of amikacin that Woolley and colleagues (2001) administered to 




of eleven days.  The first six injections were administered on days one through six 
and the last four were given on days eight through eleven.  Subjects did not receive an 
injection on day seven; instead, hearing sensitivity after six days of injections was 
assessed through the ABR.   
 
Results and Discussion 
Hearing Sensitivity 
Following amikacin treatment, zebra finch thresholds show no change in 
hearing sensitivity.  Figure 10 shows an averaged ABR audiogram displaying hearing 
thresholds for predata (n=5), day 6 (n=5), day 14 (n=3), day 23 (n=3), and day 32 
(n=2) for zebra finches administered a ten-day cycle of amikacin.  As the audiogram 
displays, after 6 days of amikacin treatment, zebra finches do not show a substantial 
shift in hearing sensitivity at any frequency.  A repeated measures ANOVA showed 
no significant difference between testing day 6 and predata across frequencies 
(F[8,32]=1.916, p>.05).  Furthermore, three days post the completion of treatment, 
thresholds still remain relatively unaffected by the ototoxic aminoglycoside.  A 
repeated measures ANOVA showed no significant difference between testing day 14 

































Figure 10: ABR audiograms before amikacin injection (red, closed-circle line), after 6 
days of amikacin injections, or day 6 (blue, downward-triangle line) 3 days post 
injections, or day 14 (green, closed-square line), 12 days post injections, or day 23 
(pink, closed-diamond line), and 22 days post injections, or day 32 (dark green, 
upward-triangle line) for the zebra finch.  The solid black line is the behavioral 
audiogram for zebra finches.  Following amikacin treatment, zebra finch ABR 
audiograms of hearing thresholds do not show a pattern of high frequency threshold 
shifts similar to those found in Bengalese finches.  Interestingly, zebra finches show 
no hearing loss due to amikacin treatment. 
 
 
Hearing sensitivity was monitored for nearly one month after the completion 
of amikacin treatment.  There was no difference in thresholds at any frequency tested.  
A repeated measures ANOVA showed no significant difference between testing day 




the administered ten-day cycle of amikacin treatment has no effect on zebra finch 
hearing sensitivity.  This is very dissimilar to results found in amikacin treated 
Bengalese finches which experience substantial threshold shifts especially at 
frequencies of 2 kHz and above (Woolley et al., 2001). 
 
Histology 
Figures 7A and C exhibit a normal zebra finch basilar papilla (7A) and the 
basilar papilla of a zebra finch treated with amikacin (7C).  Examination of the basilar 
papilla of two zebra finches (0 days post amikacin course) using phallodin staining 
showed little to no hair cell loss and damage in the basal end of the papilla (see 
Figure 7C).  Of the two ears examined, one appeared normal, presenting no damage 
in the basal or middle regions of the basilar papilla.  The second showed a very small 
area of hair cell loss and misorientation in the basal end of the papilla.  There is 
exceptionally slight hair cell loss observed in the basal end of the papilla in contrast 
to what is observed in Bengalese finches (Woolley et al., 2001).  Interestingly, the 
basilar papillae of a zebra finch treated with amikacin and a zebra finch treated with 
kanamycin both appear quite similar to the basilar papilla of a normal zebra finch (see 
Figures 7A, B, and C). 
 
General Discussion 
  These experiments sought to measure the effect of aminoglycoside treatment 
on hearing in three avian species using the ABR technique.  First, the effect of 




measured.  Budgerigar and canary ABR audiograms showed similar results to those 
found through behavioral methods in the two species (Dooling et al., 2006; Dooling 
et al., in prep).  Both species experienced an initial high frequency hearing loss which 
over time extended to also affect the mid and low frequencies.  Zebra finches did not 
show this typical high frequency hearing loss but instead showed only minor 
threshold shifts across all frequencies.  Also, histological studies suggested that there 
was little to no change in hair cells within the basilar papilla of the KM treated zebra 
finch. 
Next, the effect of a second aminoglycoside, amikacin, was examined in the 
zebra finch to determine whether the aberrant results seen with kanamycin were a 
consequence of that particular aminoglycoside, KM, or were a function of the species 
of bird itself.  Here, again, the zebra finch displayed unusual results that were 
inconsistent with those found through physiological methods in other avian species.  
Zebra finch ABR audiograms did not display the typical high frequency hearing loss 
pattern that Bengalese finches showed after amikacin treatment (Woolley et al., 
2001).  Instead, they showed very little change in hearing sensitivity, even less than 
with kanamycin.  Histological studies suggested that there was little to no change in 
hair cells within the basilar papilla of the amikacin treated zebra finch. 
The effects of the two aminoglycosides on zebra finch hearing sensitivity 
suggest that the atypical results are not limited to a specific aminoglycoside.  Overall, 
zebra finch threshold shifts as a result of aminoglycoside treatment are much smaller 
than those found in budgerigars and canaries.  There are several explanations for this 




finches possess a faster metabolism than other avian species.  This may result in a 
diluted concentration of the aminoglycoside reaching the ear.  Thus, in order for a 
robust enough concentration to affect the ear, a larger dosage may be required.  Yet, 
because aminoglycosides such as kanamycin can lead to renal failure and 
subsequently, death, as was experienced with multiple subjects in this study, an 
effective dosage may not be possible.   
It is interesting that the zebra finch also shows reduced hearing loss from 
acoustic overstimulation .  Ryals et al., (1999) showed that zebra finches exhibited far 
less hair cell loss and damage and recovered hearing sensitivity at a much faster rate 
than budgerigars and quail that were exposed to the same duration and intensity of 
noise exposure.  Additionally, hearing abilities were found to return to near normal 
levels with time, while budgerigars and quail suffered a permanent loss of 
approximately 20 dB.  Taken together, these past results and our present findings 
using KM argue for a more resistant sensory epithelium in zebra finches. 
In summary, the zebra finch appears less susceptible to hearing damage from 
ototoxic drugs than other avian species.  However, the reasons for this reduced 
susceptibility are unclear.  It might be interesting to examine the effects of a direct 
application method of KM, similar to that conducted by Husmann et al. (1998), in 
zebra finches.  Their study compared the effects of systemic injections vs. direct 
application of another aminoglycoside, gentamicin.  Broiler chickens were either 
administered doses of gentamicin through systemic injections or the direct application 
method in which sponges soaked in the antibiotic were placed directly onto the round 




a much larger amount of cochlear damage, with less toxic effects.  The direct 
application method of KM should allow for a sufficient dosage of the antibiotic to be 
administered to the zebra finch without causing the toxic and potentially lethal effects 
that are experienced through systemic injections. 
These experiments hope to lay the foundation for future research aimed at 
finding a means to reverse hearing loss in humans.  Songbirds provide a model for 
vocal learning in humans, because, like humans, they learn through auditory 
feedback.  Zebra finches are particularly popular models for vocal development and 
learning.  It is too bad zebra finches are so resistant to damage from noise or ototoxic 
drugs because studies of the effects of temporary deafness on vocal learning would be 
valuable.  Future researchers may want to find another songbird species for such 
studies.  Findings from these experiments lead to many research questions on why the 
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